On this page
Chronic bronchitis sits at the intersection of two rule sets. 38 CFR § 4.97 (opens in a new tab), Diagnostic Code 6600, grades respiratory impairment mainly through pulmonary function tests. Separately, 38 U.S.C. §§ 1119 and 1120 make chronic bronchitis presumptive for veterans who meet the statute's covered-service definition.
The presumption can establish the connection to service. It does not set the percentage. The rating still depends on PFT values or one of the severe non-PFT findings in DC 6600, applied with the special testing rules in 38 CFR § 4.96 (opens in a new tab).
This page explains both halves: the DC 6600 criteria, the post-bronchodilator rule, exactly who the PACT Act presumption covers, overlapping COPD or asthma, and why VA denies chronic bronchitis claims. If your diagnosis is COPD rather than chronic bronchitis, the COPD VA rating page covers that code and its own PACT Act entry.
TL;DR
- Chronic bronchitis is DC 6600, with ratings of 10, 30, 60, or 100 percent.
- The main measurements are FEV-1, FEV-1/FVC, and DLCO (SB). Any one of them can set the level, and when they point to different levels, VA uses the result the examiner says most accurately reflects the disability.
- VA generally uses post-bronchodilator PFT results. Section 4.96 provides exceptions and tells VA what to do when results conflict.
- Chronic bronchitis is listed in 38 U.S.C. § 1120 as presumptive for a “covered veteran” under § 1119. It is not on the 38 CFR § 3.320 list, so the statute is the authority.
- A diagnosis plus covered service can establish the presumption, but the veteran still needs current severity evidence for the rating.
- Ratings for coexisting conditions in DCs 6600 through 6817 and 6822 through 6847 are not combined. VA assigns one code reflecting the predominant respiratory disability, with possible elevation when overall severity warrants it.
- Across 2,232 decided Board rulings on chronic bronchitis from 2021 to 2026, 17.2% were granted, 33.2% denied and 49.6% remanded.
Chronic bronchitis VA rating criteria (DC 6600)
DC 6600 provides four levels.
- 10%: FEV-1 of 71 to 80 percent predicted; FEV-1/FVC of 71 to 80 percent; or DLCO (SB) of 66 to 80 percent predicted.
- 30%: FEV-1 of 56 to 70 percent predicted; FEV-1/FVC of 56 to 70 percent; or DLCO (SB) of 56 to 65 percent predicted.
- 60%: FEV-1 of 40 to 55 percent predicted; FEV-1/FVC of 40 to 55 percent; DLCO (SB) of 40 to 55 percent predicted; or maximum oxygen consumption of 15 to 20 ml/kg/min with a cardiorespiratory limit.
- 100%: FEV-1 below 40 percent predicted; FEV-1/FVC below 40 percent; DLCO (SB) below 40 percent predicted; maximum exercise capacity below 15 ml/kg/min with a cardiac or respiratory limit; cor pulmonale; right-ventricular hypertrophy; pulmonary hypertension documented by echocardiogram or catheterization; episodes of acute respiratory failure; or required outpatient oxygen therapy.
The percentages measure respiratory function, not cough frequency alone. A persistent productive cough supports the diagnosis and history, but a compensable schedular level normally needs qualifying objective impairment; when no level is met, VA assigns 0 percent (38 CFR § 4.31). For a single veteran with no dependents at the 2026 rates, the four levels pay $180.42, $552.47, $1,435.02 and $3,938.58 a month.
How VA reads your PFT (38 CFR § 4.96)
Section 4.96 prevents common mistakes in reading a PFT report.
- PFTs are generally required for DC 6600 unless a listed severe alternative applies: an exercise test of 20 ml/kg/min or less, pulmonary hypertension, cor pulmonale or right-ventricular hypertrophy, acute respiratory failure, or outpatient oxygen.
- Post-bronchodilator testing is normally required for a disability evaluation, except when pre-bronchodilator results are normal or the examiner explains why post-testing should not be done.
- VA uses post-bronchodilator values unless they are worse than the pre-bronchodilator values. In that situation, it uses the pre-bronchodilator results.
- If DLCO is missing, an examiner must explain why it would not be useful or valid before VA relies on alternatives.
- When different PFT results would produce different percentages, VA uses the result the examiner says most accurately reflects the disability.
- When both FEV-1 and FVC exceed 100 percent, VA does not assign compensation solely from a decreased FEV-1/FVC ratio.
Bring the full report, not a screenshot of one number. The interpretation, predicted percentages, bronchodilator status, DLCO method, and examiner explanation all matter.
Chronic bronchitis and the PACT Act presumption
Section 1120(b)(3) lists chronic bronchitis as a disease presumed connected to service for a covered veteran. Section 1119(c) defines covered service: on or after August 2, 1990, at a duty station in or above Bahrain, Iraq, Kuwait, Oman, Qatar, Saudi Arabia, Somalia or the United Arab Emirates, or on or after September 11, 2001, at a duty station in or above Afghanistan, Djibouti, Egypt, Jordan, Lebanon, Syria, Yemen, Uzbekistan or another country VA determines is relevant. The PACT Act guide explains the broader framework.
Here is exactly what is and is not presumptive.
- Presumptive by statute. Chronic bronchitis in a covered veteran, with no deadline for onset and no minimum severity. COPD is a separate entry in the same list; the COPD VA rating page covers it.
- Not in 38 CFR § 3.320. That regulation, as revised by the final rule at 88 FR 60336 (September 1, 2023), covers asthma, rhinitis, sinusitis and nine rare respiratory cancers. In that rule VA declined a request to add chronic bronchitis and said the PACT Act's respiratory presumptions would be handled in separate rulemaking. An October 2024 proposed rule (89 FR 79815) would add chronic bronchitis to § 3.320, but it is still a proposal, so the statute is the authority today.
- Not on the other lists. Chronic bronchitis is not on the Agent Orange, Camp Lejeune or one-year chronic disease lists in 38 CFR § 3.309. Bronchiectasis is on the one-year list; chronic bronchitis is not.
Two limits matter. The presumption can be rebutted under 38 U.S.C. § 1113 by affirmative evidence of another cause, but the evidence has to do that work: in a January 2025 decision, the Board found a VA opinion that blamed smoking without considering toxic exposure too weak to rebut it and granted chronic bronchitis and COPD (Board citation A25003600). And a presumptive award cannot take effect before August 10, 2022, the date the PACT Act became law (38 CFR § 3.114).
For a presumptive claim, the core record is a current chronic bronchitis diagnosis, military records showing qualifying service under § 1119, and current medical evidence sufficient to evaluate severity. The Airborne Hazards and Open Burn Pit Registry is a health resource. Enrollment is not a disability claim and is not required to prove covered service. Personnel records, deployment orders, and other official service evidence are more direct proof of the statutory location and period.
Veterans who do not meet the covered-service definition can still pursue direct service connection. The record then needs an in-service exposure, event, disease, or onset; a current diagnosis; and a medical nexus. Evidence of a toxic exposure risk activity can require VA to provide an exam and a nexus opinion under 38 U.S.C. § 1168, but it does not automatically establish causation.
Chronic bronchitis, COPD, and asthma
Chronic bronchitis often overlaps with COPD, and some records use the terms together. Asthma can also produce obstruction and bronchodilator response. The diagnoses and predominant disability need to be clear.
Section 4.96(a) prohibits combining ratings under respiratory DCs 6600 through 6817 and 6822 through 6847. VA assigns a single evaluation under the code reflecting the predominant disability, with elevation to the next level when the overall severity warrants it. A veteran should not simply add a DC 6600 percentage to a DC 6604 COPD percentage or a DC 6602 asthma percentage.
This rule does not mean coexisting diagnoses disappear. Their symptoms, treatment, and test results remain evidence. It means VA avoids paying multiple schedular respiratory ratings for overlapping impairment.
Why VA denies chronic bronchitis claims
Across 2,232 decided Board rulings on chronic bronchitis from 2021 to 2026, 17.2% were granted, 33.2% denied and 49.6% remanded. A ruling is one issue the Board decided in one decision; one decision often rules on several issues. That grant rate is 7.5 points below the Board-wide 24.7%, and remand is the most common outcome. When the Board denied chronic bronchitis service connection, it most often found no current diagnosis; the Board section below shows how often each part of the claim failed and why claims were sent back.
Acute-versus-chronic confusion. A short infection is documented, but the record does not establish a chronic disease.
Using the wrong PFT column. The claim relies on a raw value rather than percent predicted, or on a pre-bronchodilator result when § 4.96 requires the post result.
Missing DLCO without an explanation. The report omits a relevant measurement and does not state why it was invalid or unnecessary.
Assuming every exposure is presumptive. The veteran has credible exposure but does not meet the covered-service definition in § 1119. Direct service connection may still be available, but it is a different path.
Combining overlapping respiratory ratings. The claim adds bronchitis, COPD, and asthma percentages despite § 4.96(a).
The record that avoids these denials has the chronic diagnosis and its clinical basis; the full pre- and post-bronchodilator PFT report; DLCO, or the examiner's reason for omitting it; oxygen prescriptions; echocardiogram or catheterization evidence of pulmonary hypertension; hospital records of acute respiratory failure; exercise testing when performed; service-location evidence for a presumptive claim; and an exposure history and medical opinion for a direct claim. Also document functional effects such as walking tolerance, stair use, lifting, sleep interruption, and work restrictions. They do not replace DC 6600's objective thresholds, but they help VA evaluate the full disability and any TDIU question.
Questions veterans ask about chronic bronchitis
What is the VA rating for bronchitis?
Chronic bronchitis is rated 10, 30, 60, or 100 percent under DC 6600, mainly on FEV-1, FEV-1/FVC, and DLCO. An acute bronchitis that cleared up is not a current disability, so VA does not rate it.
What is the VA diagnostic code for bronchitis?
Diagnostic Code 6600, "Bronchitis, chronic," in 38 CFR § 4.97. The schedule also points some other conditions to DC 6600, such as residuals of a pulmonary embolism or of inactive tuberculosis when obstructive lung disease is the main residual.
Is chronic bronchitis covered by the PACT Act?
Yes. 38 U.S.C. § 1120 presumes chronic bronchitis is service connected for a covered veteran, meaning service on or after August 2, 1990 or September 11, 2001 at a duty station in a country listed in § 1119. It is not on the 38 CFR § 3.320 list, so a decision that checks only that regulation has missed the statute.
Does the PACT Act change the chronic bronchitis rating?
No. The presumption connects chronic bronchitis to service, but the percentage still comes from DC 6600 and the PFT rules in § 4.96. A presumptive award also cannot pay for any period before August 10, 2022.
Can I be rated for chronic bronchitis and COPD at the same time?
Not separately. Section 4.96(a) bars combining ratings under DCs 6600 through 6817 and 6822 through 6847, so VA assigns one rating under the predominant code, which may be DC 6604 for COPD, and can raise it one level when the overall severity warrants.
Bottom Line
Chronic bronchitis is presumptive for a statutorily covered veteran, but the rating still comes from DC 6600. Read the complete PFT under § 4.96, use the correct bronchodilator values, and check for the severe alternatives such as oxygen, pulmonary hypertension, or respiratory failure. When COPD, asthma, or another listed respiratory condition overlaps, expect one predominant respiratory rating rather than stacked percentages.
Methodology and Limitations
- Authorities checked: 38 CFR §§ 3.114, 3.309, 3.320, 4.31, 4.96 and 4.97, DC 6600, plus 38 U.S.C. §§ 1113, 1119, 1120, and 1168. Regulatory text was checked against the eCFR text current to October 2, 2026. The status of § 3.320 was checked against the final rule at 88 FR 60336 and the proposed rule at 89 FR 79815. Payment figures are the 2026 VA rates for a veteran with no dependents.
- Board practice: Board decisions apply the statute directly, for example granting chronic bronchitis under § 1120 in Board citation A25003600.
- Board statistics: Board figures come from Claim Raven's read of every Board decision from 2021 to 2026 that it holds, 510,968 decisions containing 1,376,193 rulings. That includes 2,232 decided Board rulings on chronic bronchitis (2,485 rulings in all, counting dismissed and withdrawn issues): 17.2% were granted, 33.2% denied and 49.6% remanded. The Board section on this page breaks these down by denial reason, remand reason, appeal type, medical opinion, claim theory and era; those figures are computed from the data, not typed here.
- Limitations: PFT interpretation and diagnosis are medical questions. The page explains the rating rules and does not determine whether an individual test is valid or which respiratory diagnosis is predominant. Much of the 2021 to 2026 window predates the PACT Act (August 10, 2022). Board figures are associations, not causes, and describe cases that reached the Board, not all claims filed.
